Cambridge Healthtech Institute's Fourteenth Annual

Recombinant Protein Therapeutics

( 重组蛋白质疗法 )

Fusion Proteins & Beyond

2018年1月8日 - 9日

 

Cambridge Healthtech Institute's Fourteenth Annual Recombinant Protein Therapeutics conference once again profiles the varying designs of therapeutic fusion proteins in differing stages of development, and investigates the challenges and benefits associated with these promising therapies. By combining modular building blocks that can reach targets not accessible to antibodies, Fusion Protein Therapeutics possess advantages over antibody-based therapies; their customizable functionality translates into lower patient dosing, reduced production costs, and improved product homogeneity. This conference will disclose how these molecules are being engineered to form more efficacious therapeutics that offer specificity with enhanced stability and longer half-life. Case studies from international experts will be presented covering R&D through clinical data.

We invite presentation proposals on the following preliminary topics:

  • Molecule design
  • Linkers & conjugation
  • Fc Engineering
  • Immunogenicity
  • Case studies
  • Stability
  • Antibody/Domain-based fusions
  • Pharmacological activity
  • Prolonging half life
  • Assays
  • Binding
  • Delivery
  • Cytotoxic effects
  • Bifunctional fusion proteins
  • Chimeric proteins
  • Receptor traps
  • Pre-clinical development
  • Clinical data
  • Formulation technologies

* 活动内容有可能不事先告知作更动及调整。